Drug Type Non-recombinant coagulation factor |
Synonyms- |
Mechanism F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators) + [1] |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blood Coagulation Disorders | NDA/BLA | CN | 29 Apr 2022 | |
Hemophilia B | Phase 3 | CN | 26 Sep 2024 | |
Acquired coagulation factor deficiency | IND Approval | CN | 29 Aug 2024 |